Florent G, Lobmann M, Beare A S, Zygraich N
Arch Virol. 1977;54(1-2):19-28. doi: 10.1007/BF01314375.
Extensive use of recombinants made from A/PR/8/34 (H0N1) and wild, virulent H3N2 viruses as live influenza vaccines has provided a number of viruses of defined virulence for man. Clinical symptoms produced by these strains have ranged from febrile influenza to local coryzal symptoms or nil. A study was therefore made of the extent to which the PR8 genome had been incorporated into that of a number of the recombinants. By RNA--RNA hybridization it seemed that recombinants which had 55 per cent of greater homology with the PR8 parent were likely to conform an acceptable standard of attenuation. Those with lesser homology were frequently, but not always, clinically virulent. The technique seemed potentially useful, therefore, for screening PR8 live vaccine recombinants in vitro before giving them to volunteers.
大量使用由A/PR/8/34(H0N1)和野生强毒H3N2病毒制成的重组体作为流感活疫苗,已产生了许多对人类毒力明确的病毒。这些毒株引起的临床症状从发热性流感到局部鼻卡他症状不等,或无任何症状。因此,对PR8基因组整合到一些重组体基因组中的程度进行了研究。通过RNA-RNA杂交发现,与PR8亲本具有55%或更高同源性的重组体可能符合可接受的减毒标准。同源性较低的重组体通常(但并非总是)具有临床毒力。因此,这项技术在将PR8活疫苗重组体给予志愿者之前,似乎可用于体外筛选。